Sesen Bio Inc. [SESN] is -0.85% lower this YTD. Is it still time to buy?


Sesen Bio Inc. [NASDAQ: SESN] gained 16.66% or 0.12 points to close at $0.81 with a heavy trading volume of 5199733 shares. The company report on July 18, 2022 that Sesen Bio Announces Strategic Decision to Pause Clinical Development of Vicineum™ in the US.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Company intends to seek a partner for further development of Vicineum.

Sesen Bio continues to focus on the assessment of potential strategic alternatives.

It opened the trading session at $0.69, the shares rose to $0.86 and dropped to $0.6866, the range by which the price of stock traded the whole day. The daily chart for SESN points out that the company has recorded 11.77% gains over the past six months. However, it is still -118.92% lower than its most recent low trading price.

If we look at the average trading volume of 5.98M shares, SESN reached to a volume of 5199733 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Sesen Bio Inc. [SESN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SESN shares is $0.56 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SESN stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

H.C. Wainwright have made an estimate for Sesen Bio Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 16, 2021. The new note on the price target was released on June 11, 2019, representing the official price target for Sesen Bio Inc. stock.

The Average True Range (ATR) for Sesen Bio Inc. is set at 0.09, with the Price to Sales ratio for SESN stock in the period of the last 12 months amounting to 7.57. The Price to Book ratio for the last quarter was 0.93, with the Price to Cash per share for the same quarter was set at 0.82.

Trading performance analysis for SESN stock

Sesen Bio Inc. [SESN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 17.95. With this latest performance, SESN shares dropped by -1.29% in over the last four-week period, additionally plugging by 11.77% over the last 6 months – not to mention a drop of -79.01% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SESN stock in for the last two-week period is set at 55.50, with the RSI for the last a single of trading hit 58.70, and the three-weeks RSI is set at 54.75 for Sesen Bio Inc. [SESN]. The present Moving Average for the last 50 days of trading for this stock 0.7037, while it was recorded at 0.6901 for the last single week of trading, and 0.7640 for the last 200 days.

Sesen Bio Inc. [SESN]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Sesen Bio Inc. [SESN] shares currently have an operating margin of -106.09 and a Gross Margin at +99.68. Sesen Bio Inc.’s Net Margin is presently recorded at -1.27.

Return on Equity for this stock declined to -0.41, with Return on Assets sitting at -0.13.

Sesen Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 21.30 and a Current Ratio set at 21.30.

An analysis of insider ownership at Sesen Bio Inc. [SESN]

There are presently around $36 million, or 22.50% of SESN stock, in the hands of institutional investors. The top three institutional holders of SESN stocks are: BLACKROCK INC. with ownership of 13,387,891, which is approximately -0.747% of the company’s market cap and around 1.00% of the total institutional ownership; VANGUARD GROUP INC, holding 12,694,776 shares of the stock with an approximate value of $10.26 million in SESN stocks shares; and STATE STREET CORP, currently with $3.51 million in SESN stock with ownership of nearly 1.219% of the company’s market capitalization.

Positions in Sesen Bio Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 23 institutional holders increased their position in Sesen Bio Inc. [NASDAQ:SESN] by around 2,494,330 shares. Additionally, 50 investors decreased positions by around 6,021,399 shares, while 29 investors held positions by with 36,513,470 shares. The mentioned changes placed institutional holdings at 45,029,199 shares, according to the latest SEC report filing. SESN stock had 9 new institutional investments in for a total of 1,940,776 shares, while 18 institutional investors sold positions of 1,807,840 shares during the same period.